Calithera Biosciences Lands $1,999,999 Series C Funding

  • Feed Type
  • Date
    12/31/2012
  • Company Name
    Calithera Biosciences
  • Mailing Address
    341 Oyster Point Blvd. South San Francisco, CA 94080
  • Company Description
    The primary mission of Calithera Biosciences is to develop novel therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. Our first program is focused on developing activators of caspases, the proteases that induce apoptosis, for the treatment of cancer. The approach of discovering activators of enzymes has the potential to be a unique and broadly applicable technology platform for developing therapies to multiple oncology indications.
  • Website
    http://www.calithera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,999,999
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.